199 related articles for article (PubMed ID: 23907583)
1. Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay.
Kang M; Kim SY; An SS; Ju YR
Exp Mol Med; 2013 Aug; 45(8):e34. PubMed ID: 23907583
[TBL] [Abstract][Full Text] [Related]
2. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
3. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
[TBL] [Abstract][Full Text] [Related]
4. Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen.
Van Giau V; An SSA
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678343
[TBL] [Abstract][Full Text] [Related]
5. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus.
Li R; Liu T; Wong BS; Pan T; Morillas M; Swietnicki W; O'Rourke K; Gambetti P; Surewicz WK; Sy MS
J Mol Biol; 2000 Aug; 301(3):567-73. PubMed ID: 10966770
[TBL] [Abstract][Full Text] [Related]
6. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
7. [Production of monoclonal antibodies to the prion protein and their characterization].
Oboznaia MB; Vladimirova NM; Titova MA; Volkova TD; Koroev DO; Riabokon' AA; Egorov AA; Rybakov SS; Vol'pina OM
Bioorg Khim; 2008; 34(6):754-63. PubMed ID: 19088748
[TBL] [Abstract][Full Text] [Related]
8. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
9. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
Taylor DR; Hooper NM
Semin Cell Dev Biol; 2007 Oct; 18(5):638-48. PubMed ID: 17822928
[TBL] [Abstract][Full Text] [Related]
10. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition.
Williams TL; Choi JK; Surewicz K; Surewicz WK
ACS Chem Neurosci; 2015 Dec; 6(12):1972-80. PubMed ID: 26466138
[TBL] [Abstract][Full Text] [Related]
11. Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases.
Tapella L; Stravalaci M; Bastone A; Biasini E; Gobbi M; Chiesa R
Biochem J; 2013 Sep; 454(3):417-25. PubMed ID: 23808898
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
13. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
14. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.
Parkin ET; Watt NT; Hussain I; Eckman EA; Eckman CB; Manson JC; Baybutt HN; Turner AJ; Hooper NM
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11062-7. PubMed ID: 17573534
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
16. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
Haas LT; Salazar SV; Kostylev MA; Um JW; Kaufman AC; Strittmatter SM
Brain; 2016 Feb; 139(Pt 2):526-46. PubMed ID: 26667279
[TBL] [Abstract][Full Text] [Related]
18. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
Aimi T; Suzuki K; Hoshino T; Mizushima T
J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
[TBL] [Abstract][Full Text] [Related]
19. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
20. The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP).
Gielnik M; Zhukova L; Zhukov I; Gräslund A; Kozak M; Wärmländer S
Acta Biochim Pol; 2022 Feb; 69(1):257-261. PubMed ID: 35143147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
